Literature DB >> 31097609

The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease (PSP-CKD) Study: A Cluster Randomized Trial in Primary Care.

Rupert W Major1,2, Celia Brown3, David Shepherd1, Stephen Rogers1, Warren Pickering4, Graham L Warwick2, Shaun Barber5, Nuzhat B Ashra5, Tom Morris5, Nigel J Brunskill6,7.   

Abstract

BACKGROUND: Most patients with CKD are managed in the community. Whether nurse-led CKD management programs improve outcomes in patients with CKD in primary care is unclear.
METHODS: To assess the effect of such a program on the rate of renal function decline in patients with CKD (stages 3-5) in primary care in the United Kingdom, we conducted a cluster randomized trial, the Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease study. A software program designed for the study created a data file of patients with CKD in participating practices. In 23 intervention practices (11,651 patients), a CKD nurse practitioner worked with nominated practice leads to interpret the data file and implement guideline-based patient-level CKD management interventions. The 23 control practices (11,706 patients) received a data file but otherwise, continued usual CKD care. The primary outcome was defined at the cluster (practice) level as the change from baseline of the mean eGFR of the patients with CKD at 6-month intervals up to 42 months. Secondary outcomes included numbers of patients coded for CKD, mean BP, numbers of patients achieving National Institute for Health and Care Excellence BP targets for CKD, and proteinuria measurement.
RESULTS: After 42 months, eGFR did not differ significantly between control and intervention groups. CKD- and proteinuria-related coding improved significantly along with the number of patients achieving BP targets in the intervention group versus usual care.
CONCLUSIONS: CKD management programs in primary care may not slow progression of CKD, but they may significantly improve processes of care and potentially decrease the cardiovascular disease burden in CKD and related costs.
Copyright © 2019 by the American Society of Nephrology.

Entities:  

Keywords:  chronic kidney disease; clinical trial; nurse intervention; primary care

Mesh:

Year:  2019        PMID: 31097609      PMCID: PMC6622412          DOI: 10.1681/ASN.2018101042

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  31 in total

1.  Populating an economic model with health state utility values: moving toward better practice.

Authors:  Roberta Ara; John E Brazier
Journal:  Value Health       Date:  2010-03-10       Impact factor: 5.725

2.  Determinants of the intracluster correlation coefficient in cluster randomized trials: the case of implementation research.

Authors:  Marion K Campbell; Peter M Fayers; Jeremy M Grimshaw
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

3.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

Review 4.  Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease.

Authors:  G F M Strippoli; C Bonifati; M Craig; S D Navaneethan; J C Craig
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

5.  Use of process measures to monitor the quality of clinical practice.

Authors:  Richard J Lilford; Celia A Brown; Jon Nicholl
Journal:  BMJ       Date:  2007-09-29

6.  Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.

Authors:  Piero Ruggenenti; Annalisa Perna; Giacomina Loriga; Maria Ganeva; Bogdan Ene-Iordache; Marta Turturro; Maria Lesti; Elena Perticucci; Ivan Nediyalkov Chakarski; Daniela Leonardis; Giovanni Garini; Adalberto Sessa; Carlo Basile; Mirella Alpa; Renzo Scanziani; Gianbattista Sorba; Carmine Zoccali; Giuseppe Remuzzi
Journal:  Lancet       Date:  2005 Mar 12-18       Impact factor: 79.321

7.  Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.

Authors:  Chi-yuan Hsu; Charles E McCulloch; Jeanne Darbinian; Alan S Go; Carlos Iribarren
Journal:  Arch Intern Med       Date:  2005-04-25

8.  Age affects outcomes in chronic kidney disease.

Authors:  Ann M O'Hare; Andy I Choi; Daniel Bertenthal; Peter Bacchetti; Amit X Garg; James S Kaufman; Louise C Walter; Kala M Mehta; Michael A Steinman; Michael Allon; William M McClellan; C Seth Landefeld
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

9.  Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes.

Authors:  Nick Richards; Kevin Harris; Malcolm Whitfield; Donal O'Donoghue; Robert Lewis; Martin Mansell; Stephen Thomas; John Townend; Mick Eames; Daniele Marcelli
Journal:  Nephrol Dial Transplant       Date:  2007-12-09       Impact factor: 5.992

10.  Chronic kidney disease management in the United Kingdom: NEOERICA project results.

Authors:  P E Stevens; D J O'Donoghue; S de Lusignan; J Van Vlymen; B Klebe; R Middleton; N Hague; J New; C K T Farmer
Journal:  Kidney Int       Date:  2007-04-18       Impact factor: 10.612

View more
  7 in total

1.  Electronic Decision Support for Management of CKD in Primary Care: A Pragmatic Randomized Trial.

Authors:  Carmen A Peralta; Jennifer Livaudais-Toman; Marilyn Stebbins; Lowell Lo; Andrew Robinson; Sarita Pathak; Rebecca Scherzer; Leah S Karliner
Journal:  Am J Kidney Dis       Date:  2020-07-22       Impact factor: 8.860

2.  Referring patients with chronic kidney disease back to primary care: a criteria-based analysis in outpatient renal clinics.

Authors:  Carola van Dipten; Davy Gerda Hermina Antoin van Dam; Wilhelmus Joannes Carolus de Grauw; Marcus Antonius Gerard Jan Ten Dam; Marcus Matheus Hendrik Hermans; Willem Jan Jozef Assendelft; Nynke Dorothea Scherpbier-de Haan; Jacobus Franciscus Maria Wetzels
Journal:  BMC Nephrol       Date:  2021-05-19       Impact factor: 2.388

3.  Effects of a Knowledge-Translation Intervention on Early Dialysis Initiation: A Cluster Randomized Trial.

Authors:  Navdeep Tangri; Amit X Garg; Thomas W Ferguson; Stephanie Dixon; Claudio Rigatto; Selina Allu; Elaine Chau; Paul Komenda; David Naimark; Gihad E Nesrallah; Steven D Soroka; Monica Beaulieu; Ahsan Alam; S Joseph Kim; Manish M Sood; Braden Manns
Journal:  J Am Soc Nephrol       Date:  2021-04-15       Impact factor: 14.978

4.  Patients' and kidney care team's perspectives of treatment burden and capacity in older people with chronic kidney disease: a qualitative study.

Authors:  Hilda O Hounkpatin; Geraldine M Leydon; Kristin Veighey; Kirsten Armstrong; Miriam Santer; Maarten W Taal; Pete Annells; Carl May; Paul J Roderick; Simon Ds Fraser
Journal:  BMJ Open       Date:  2020-12-12       Impact factor: 2.692

5.  Health-related quality of life, functional impairment and comorbidity in people with mild-to-moderate chronic kidney disease: a cross-sectional study.

Authors:  Simon Ds Fraser; Jenny Barker; Paul J Roderick; Ho Ming Yuen; Adam Shardlow; James E Morris; Natasha J McIntyre; Richard J Fluck; Chris W McIntyre; Maarten W Taal
Journal:  BMJ Open       Date:  2020-08-06       Impact factor: 2.692

6.  Mixed-effects models for health care longitudinal data with an informative visiting process: A Monte Carlo simulation study.

Authors:  Alessandro Gasparini; Keith R Abrams; Jessica K Barrett; Rupert W Major; Michael J Sweeting; Nigel J Brunskill; Michael J Crowther
Journal:  Stat Neerl       Date:  2019-09-05       Impact factor: 1.190

7.  Tackling Dialysis Burden around the World: A Global Challenge.

Authors:  Philip Kam-Tao Li; Gordon Chun-Kau Chan; Jianghua Chen; Hung-Chun Chen; Yuk-Lun Cheng; Stanley L-S Fan; John Cijiang He; Weixin Hu; Wai-Hon Lim; York Pei; Boon Wee Teo; Ping Zhang; Xueqing Yu; Zhi-Hong Liu
Journal:  Kidney Dis (Basel)       Date:  2021-04-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.